Literature DB >> 15866030

Probing phosphoinositide functions in signaling and membrane trafficking.

C Peter Downes1, Alex Gray, John M Lucocq.   

Abstract

The inositol phospholipids (PIs) comprise a family of eight species with different combinations of phosphate groups arranged around the inositol ring. PIs are among the most versatile signaling molecules known, with key roles in receptor-mediated signal transduction, actin remodeling and membrane trafficking. Recent studies have identified effector proteins and specific lipid-binding domains through which PIs signal. These lipid-binding domains can be used as probes to further our understanding of the spatial and temporal control of individual PI species. New layers of complexity revealed by the use of such probes include the occurrence of PIs at intracellular locations, the identification of phosphatidylinositol signaling hotspots and the presence of non-membrane pools of PIs in cell nuclei.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866030     DOI: 10.1016/j.tcb.2005.03.008

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  84 in total

1.  A highly dynamic ER-derived phosphatidylinositol-synthesizing organelle supplies phosphoinositides to cellular membranes.

Authors:  Yeun Ju Kim; Maria Luisa Guzman-Hernandez; Tamas Balla
Journal:  Dev Cell       Date:  2011-11-15       Impact factor: 12.270

2.  The inositol Inpp5k 5-phosphatase affects osmoregulation through the vasopressin-aquaporin 2 pathway in the collecting system.

Authors:  Eileen Pernot; Sara Terryn; Siew Chiat Cheong; Nicolas Markadieu; Sylvie Janas; Marianne Blockmans; Monique Jacoby; Valérie Pouillon; Stéphanie Gayral; Bernard C Rossier; Renaud Beauwens; Christophe Erneux; Olivier Devuyst; Stéphane Schurmans
Journal:  Pflugers Arch       Date:  2011-09-22       Impact factor: 3.657

3.  Quantitative assessment of specificity in immunoelectron microscopy.

Authors:  John Milton Lucocq; Christian Gawden-Bone
Journal:  J Histochem Cytochem       Date:  2010-05-10       Impact factor: 2.479

Review 4.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 5.  Plasmodesmata viewed as specialised membrane adhesion sites.

Authors:  Jens Tilsner; Khalid Amari; Lesley Torrance
Journal:  Protoplasma       Date:  2010-10-12       Impact factor: 3.356

Review 6.  Probing enzyme phosphoester interactions by combining mutagenesis and chemical modification of phosphate ester oxygens.

Authors:  James T Stivers; Rajesh Nagarajan
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

Review 7.  Supervised membrane swimming: small G-protein lifeguards regulate PIPK signalling and monitor intracellular PtdIns(4,5)P2 pools.

Authors:  Megan Santarius; Chang Ho Lee; Richard A Anderson
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

8.  FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.

Authors:  Katarzyna A Ellsworth; Irene Moon; Bruce W Eckloff; Brooke L Fridley; Gregory D Jenkins; Anthony Batzler; Joanna M Biernacka; Ryan Abo; Abra Brisbin; Yuan Ji; Scott Hebbring; Eric D Wieben; David A Mrazek; Richard M Weinshilboum; Liewei Wang
Journal:  Pharmacogenet Genomics       Date:  2013-03       Impact factor: 2.089

9.  Localization of phosphatidylinositol (3,4,5)-trisphosphate to phagosomes in entamoeba histolytica achieved using glutathione S-transferase- and green fluorescent protein-tagged lipid biosensors.

Authors:  Yevgeniya A Byekova; Rhonda R Powell; Brenda H Welter; Lesly A Temesvari
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

10.  Spatial Segregation of Phosphatidylinositol 4,5-Bisphosphate (PIP(2)) Signaling in Immune Cell Functions.

Authors:  Corey M Johnson; William Rodgers
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2008-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.